BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6889881)

  • 1. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats.
    Vergnes M; Kempf E
    Behav Brain Res; 1982 Aug; 5(4):387-97. PubMed ID: 6889881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion.
    Vergnes M; Depaulis A; Boehrer A; Kempf E
    Behav Brain Res; 1988 Jul; 29(1-2):85-91. PubMed ID: 3401325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
    Applegate CD
    Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
    [No Abstract]   [Full Text] [Related]  

  • 6. Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection.
    Frankfurt M; Azmitia E
    Brain Res; 1984 Apr; 298(2):273-82. PubMed ID: 6609746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
    Frankfurt M; Azmitia E
    Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrahypothalamic 5,7-dihydroxytryptamine: temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior.
    Frankfurt M; Renner K; Azmitia E; Luine V
    Brain Res; 1985 Aug; 340(1):127-33. PubMed ID: 4027638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
    Pranzatelli MR; Snodgrass SR
    Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rostral hypothalamic microinfusions of 5,7 dihydroxytryptamine produce anatomically and neurochemically selective depletions of hippocampal serotonin and increase the influence of estrogen and food deprivation on locomotor activity.
    Waldbillig RJ; Weider GE; Clemmons RM; Bartness TJ
    Brain Res; 1985 Nov; 347(1):149-53. PubMed ID: 4052795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria.
    Williams JH; Azmitia EC
    Brain Res; 1981 Feb; 207(1):95-107. PubMed ID: 7470907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
    Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
    Hard E; Ahlenius S; Engel J
    Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypothalamic serotonin depletion on lordosis behavior and gonadal hormone receptors.
    Luine VN; Thornton JE; Frankfurt M; MacLusky NJ
    Brain Res; 1987 Nov; 426(1):47-54. PubMed ID: 3690318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
    Paris JM; Mitsushio H; Lorens SA
    Brain Res; 1989 Jan; 476(1):183-8. PubMed ID: 2464417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serotonergic neurons in dorsal raphe, median raphe and anterior hypothalamic pressor mechanisms.
    Robinson SE; Austin MJ; Gibbens DM
    Neuropharmacology; 1985 Jan; 24(1):51-8. PubMed ID: 3982602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.